Attached files

file filename
EX-32.2 - EX-32.2 - SUPERNUS PHARMACEUTICALS, INC.a2231272zex-32_2.htm
EX-32.1 - EX-32.1 - SUPERNUS PHARMACEUTICALS, INC.a2231272zex-32_1.htm
EX-31.2 - EX-31.2 - SUPERNUS PHARMACEUTICALS, INC.a2231272zex-31_2.htm
EX-31.1 - EX-31.1 - SUPERNUS PHARMACEUTICALS, INC.a2231272zex-31_1.htm
EX-23.2 - EX-23.2 - SUPERNUS PHARMACEUTICALS, INC.a2231272zex-23_2.htm
10-K - 10-K - SUPERNUS PHARMACEUTICALS, INC.a2231272z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statements:

    1)    Registration Statement (Form S-8 No. 333-181479) pertaining to the 2005 Stock Plan, the 2012 Equity Incentive Plan, and the 2012 Employee Stock Purchase Plan of Supernus Pharmaceuticals, Inc.

    2)    Registration Statement (Form S-3 No. 333-200716) of Supernus Pharmaceuticals, Inc.

    3)    Registration Statement (Form S-8 No. 333-201049) pertaining to the Amended and Restated 2012 Equity Incentive Plan and the Amended and Restated 2012 Employee Stock Purchase Plan of Supernus Pharmaceuticals, Inc.

    4)    Registration Statement (Form S-8 No. 333-216135) pertaining to the Second Amended and Restated 2012 Equity Incentive Plan and the Second Amended and Restated 2012 Employee Stock Purchase Plan of Supernus Pharmaceuticals, Inc.

of our report dated March 12, 2015, except for Note 2, as to which the date is January 20, 2017, with respect to the consolidated financial statements of Supernus Pharmaceuticals, Inc., as of and for the year ended December 31, 2014, included in this Annual Report (Form 10-K) for the year ended December 31, 2016.

/s/ Ernst & Young    

McLean, VA
March 13, 2017

 

 

1




QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM